Effective Deactivation of A549 Tumor Cells in Vitro and in Vivo by RGD-decorated Chitosan-Functionalized Single-Walled Carbon Nanotube Loading Docetaxel

Bin Li,Xiao-Xue Zhang,Hao-Yan Huang,Li-Qing Chen,Jing-Hao Cui,Yanli Liu,Hehua Jin,Beom-Jin Lee,Qing-Ri Cao
DOI: https://doi.org/10.1016/j.ijpharm.2018.03.017
IF: 6.51
2018-01-01
International Journal of Pharmaceutics
Abstract:This study aims to construct and evaluate RGD-decorated chitosan (CS)-functionalized pH-responsive single-walled carbon nanotube (SWCNT) carriers using docetaxel (DTX) as a model anticancer drug. DTX was loaded onto SWCNT via π-π stacking interaction (SWCNT-DTX), followed by the non-covalent conjugation of RGD-decorated CS to SWCNT-DTX to prepare RGD-CS-SWCNT-DTX. The RGD-CS-SWCNT-DTX showed significantly higher drug release than the pure drug, giving higher release rate at pH 5.0 (68%) than pH 7.4 (49%). The RGD-CS-SWCNT-DTX could significantly inhibit the growth of A549 tumor cells in vitro, and the uptake amount of A549 cells was obviously higher than that of MCF-7 cells. Meanwhile, the cellular uptake of RGD-CS-SWCNT-DTX was higher than that of CS-SWCNT-DTX in A549 cells, mainly through clathrin and caveolae-mediated endocytosis. The RGD-CS-SWCNT-DTX significantly inhibited tumor growth of A549 cell-bearing nude mice through active tumor-targeting ability. Furthermore, no pathological changes were found in tissues and organs. The result demonstrated that RGD-CS-SWCNT-DTX displayed high drug loading, pH-responsive drug release, remarkable antitumor effect in vitro and in vivo, and also good safety to animal body.
What problem does this paper attempt to address?